Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 5,212 | 4,729 | 4,764 | 4,419 | 4,877 |
| Cost of Goods | 2,219 | 1,968 | 1,849 | 1,624 | 1,723 |
| Gross Profit | 2,993 | 2,761 | 2,915 | 2,795 | 3,154 |
| Operating Expenses | 3,115 | 3,711 | 3,450 | 3,171 | 3,311 |
| Operating Income | 97 | 18 | 314 | 248 | 566 |
| Interest Expense | 0 | 0 | 0 | 1 | 0 |
| Other Income | 43 | 44 | 26 | -1 | -8 |
| Pre-tax Income | 140 | 62 | 340 | 246 | 558 |
| Income Tax | N/A | N/A | 3 | 9 | N/A |
| Net Income Continuous | 140 | 62 | 337 | 237 | 558 |
| Net Income | $140 | $62 | $337 | $237 | $558 |
| EPS Basic Total Ops | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| EPS Basic Continuous Ops | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| EPS Diluted Total Ops | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| EPS Diluted Continuous Ops | 0.01 | 0.00 | 0.03 | 0.02 | 0.05 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.01 | 0.03 | 0.02 | 0.05 |
| EBITDA(a) | $124 | $50 | $348 | $281 | $606 |